ISHARES TR - U.S. MED DVC ETF (IHI)

CUSIP: 464288810

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / U.S. MED DVC ETF
Total 13F shares
28,066,095
Share change
-2,307,412
Total reported value
$1,686,567,273
Put/Call ratio
37%
Price per share
$60.08
Number of holders
519
Value change
-$139,681,287
Number of buys
147
Number of sells
279

Security key

464288810

Report period

Q3 2025

Institutions

519

Top holders

10

Ownership snapshot

Top shareholders of IHI - ISHARES TR - U.S. MED DVC ETF (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
13D/G signal
Evidence rows
0
Latest as of
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
519
Shares
28,066,095
Rows loaded
520
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
541
Q3 2025 holders
519
Holder diff
-22
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 value Q3 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .